Oncolytics Biotech Inc. (ONCY) Social Stream



Oncolytics Biotech Inc. (ONCY): $1.18

0.03 (+2.61%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add ONCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#167 of 328

in industry

Featured Post From StockTwits About ONCY

$ONCY Q2 results & update.
I was neither disappointed or excited. In- of- itself, the information was well presented, structured etc.
It was mentioned that “something seems different this time”?
a great statement & certainly worth some thought.
My opinion & that is all it is “ my opinion”..They seemed much less caring, concerned, desperate in this presentation.
My take away, they are happy with the existing outlook, don’t need to please anyone & know, soon enough there will be action.
Matt did mention very clearly they are contractually bound by what results they can release from the Incyt study.
Again solidifying my theory that ONC has NOT been steering the ship for some time.
The pharma partners asked for various trial data, prior to any deals.
It was mentioned a few times, “ we have successfully achieved expected results, and anticipate more of the same”
like I said; they reported not with excitement, but With as a mater of fact confidences.
Canadafan14, published August 8, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!